治療組,溶栓酶,安慰劑,p-values
1st Australian,n=264,n=253,
死亡人數,26 (9.8%),32 (12.6%),p = 0.32
評價指標,Risk ratio,0.78 (95% CI: 0.48 to 1.27),
ISIS-2,n=8592,n=8595,
死亡人數,791 (9.2%),1029 (12.0%),p < 0.001
評價指標,Risk ratio,0.77 (95% CI: 0.70 to 0.84),